Abstract
Background: It is likely that disease specific infectious morbidity is under-reported. Microbiologically identifiable diseases may be "hidden" in ICD-10 code as "unspecified" disease.
Aims: To estimate the proportion of "unspecified" morbidity of infectious cause in infants and young children reported by Hospital Episode Statistics (HES) in England in 1999 that could reasonably be attributed to Streptococcus pneumoniae, and to calculate what number and proportion of diseases could potentially be prevented by a programme of pneumococcal conjugate vaccination.
Methods: Proportions of HES "unspecified" septicaemia, meningitis, and pneumonia attributable to pneumococcal infection were estimated by applying theoretical rates obtained from studies using highly sensitive diagnostic tests. The numbers obtained were added to those coded as pneumococcal in origin. The vaccine preventable proportion was then calculated using serogroup coverage, disease specific efficacy, and vaccine uptake.
Results: For infants and children 3 months to 5 years of age in 1999, HES reported 134, 245, and 216 episodes of pneumococcal septicaemia, meningitis, and pneumonia respectively. In addition, 68, 36, and 2548 episodes of "unspecified" disease respectively are probably pneumococcal in origin. For hospitalisations in England in this age group, 157/202 (78%) cases of pneumococcal septicaemia, 218/281 (76%) cases of pneumococcal meningitis, and 452/2764 (16%) cases of pneumococcal pneumonia may be preventable annually by means of pneumococcal conjugate vaccination.
Conclusions: Paediatric hospital morbidity in England due to pneumococcal septicaemia, meningitis, and pneumonia is under-reported by 34%, 13% and 92% respectively. A larger proportion of morbidity is preventable than implied by ICD-10 code alone.
Full Text
The Full Text of this article is available as a PDF (94.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berkley J. A., Mwangi I., Ngetsa C. J., Mwarumba S., Lowe B. S., Marsh K., Newton C. R. Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. Lancet. 2001 Jun 2;357(9270):1753–1757. doi: 10.1016/S0140-6736(00)04897-2. [DOI] [PubMed] [Google Scholar]
- Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J. R., Elvin L., Ensor K. M., Hackell J., Siber G. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar;19(3):187–195. doi: 10.1097/00006454-200003000-00003. [DOI] [PubMed] [Google Scholar]
- Black Steven B., Shinefield Henry R., Ling Stella, Hansen John, Fireman Bruce, Spring David, Noyes Jack, Lewis Edwin, Ray Paula, Lee Janelle. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia. Pediatr Infect Dis J. 2002 Sep;21(9):810–815. doi: 10.1097/00006454-200209000-00005. [DOI] [PubMed] [Google Scholar]
- Dagan R., Shriker O., Hazan I., Leibovitz E., Greenberg D., Schlaeffer F., Levy R. Prospective study to determine clinical relevance of detection of pneumococcal DNA in sera of children by PCR. J Clin Microbiol. 1998 Mar;36(3):669–673. doi: 10.1128/jcm.36.3.669-673.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Finn A., Booy R., Moxon R., Sharland M., Heath P. Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child. 2002 Jul;87(1):18–21. doi: 10.1136/adc.87.1.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lee G. M., Fleisher G. R., Harper M. B. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. 2001 Oct;108(4):835–844. doi: 10.1542/peds.108.4.835. [DOI] [PubMed] [Google Scholar]
- McIntosh E. D. G., Booy R. Invasive pneumococcal disease in England and Wales: what is the true burden and what is the potential for prevention using 7 valent pneumococcal conjugate vaccine? Arch Dis Child. 2002 Jun;86(6):403–406. doi: 10.1136/adc.86.6.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller E., Waight P., Efstratiou A., Brisson M., Johnson A., George R. Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998. Acta Paediatr Suppl. 2000 Dec;89(435):11–16. doi: 10.1111/j.1651-2227.2000.tb00776.x. [DOI] [PubMed] [Google Scholar]
- Sleeman K., Knox K., George R., Miller E., Waight P., Griffiths D., Efstratiou A., Broughton K., Mayon-White R. T., Moxon E. R. Invasive pneumococcal disease in England and Wales: vaccination implications. J Infect Dis. 2000 Dec 21;183(2):239–246. doi: 10.1086/317924. [DOI] [PubMed] [Google Scholar]
- Toikka P., Nikkari S., Ruuskanen O., Leinonen M., Mertsola J. Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol. 1999 Mar;37(3):633–637. doi: 10.1128/jcm.37.3.633-637.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turett G. S., Blum S., Telzak E. E. Recurrent pneumococcal bacteremia: risk factors and outcomes. Arch Intern Med. 2001 Sep 24;161(17):2141–2144. doi: 10.1001/archinte.161.17.2141. [DOI] [PubMed] [Google Scholar]
- Zhang Y., Isaacman D. J., Wadowsky R. M., Rydquist-White J., Post J. C., Ehrlich G. D. Detection of Streptococcus pneumoniae in whole blood by PCR. J Clin Microbiol. 1995 Mar;33(3):596–601. doi: 10.1128/jcm.33.3.596-601.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]